In this paper our studies about the sequential testing program for predicting and identificating carcinogens, sequential discriminant method and cost- effectiveness analysis are summarized. The analysis of our databas...In this paper our studies about the sequential testing program for predicting and identificating carcinogens, sequential discriminant method and cost- effectiveness analysis are summarized. The analysis of our database of carcinogeniclty and genotoxicity of chemicals demonstrates the uncertainty . of short- term tests ( STTs ) to predict carcinogens and the results of most routine STTs are statistically dependent. We recommend the sequential testing program combining STTs and carclnogenicity assay, the optimal STT batteries, the rules of the sequential discrimination and the preferal choices of STTs tor specific chemical class. For illustrative pmposes the carclnogenicity prediction of several sample chamicals is presented. The results of cost-effectiveness analysis suggest that this program has vast social-economic effectiveness.展开更多
目的从遗传毒理学角度探讨磷酸镁骨黏合剂(magnesium phosphate cement,MPC)的遗传毒理学特性,为其在骨缺损修复领域的临床应用提供依据。方法将磷酸镁骨黏合剂制备浸提液,生理盐水作为阴性对照,采用程序外DNA合成(unscheduled DNA synt...目的从遗传毒理学角度探讨磷酸镁骨黏合剂(magnesium phosphate cement,MPC)的遗传毒理学特性,为其在骨缺损修复领域的临床应用提供依据。方法将磷酸镁骨黏合剂制备浸提液,生理盐水作为阴性对照,采用程序外DNA合成(unscheduled DNA synthesis,UDS)检测法,硫酸镍为阳性对照,对渗入氚标记的胸腺嘧啶核苷(3H-TdR)的人外周血淋巴细胞液DNA做液体闪烁计数,测定3H-TdR掺入量的每分钟放射计数(radio counting per minute,CPM)值;采用小鼠骨髓嗜多染红细胞核试验,阳性对照组为环磷酰胺(CPA),测试其对小鼠股骨骨髓嗜多染红细胞的微核率。结果UDS试验结果显示:实验组(MPC浸提液)的CPM均值为35.98,而阴性对照组的CPM值仅为14.75,实验组不同浓度MPC浸出液的CPM值均略高于阴性对照组(生理盐水组),但差异无显著的统计学意义(P>0.05)。然而,考虑实验组MPC浸提液的CPM均值(35.98)远低于阳性对照组(不同浓度NiSO4)的CPM均值(415.38),且有显著的统计学差异(P<0.01)。因此,可以认为MPC浸提液不会引起DNA损伤。微核试验的结果显示:实验组引起股骨骨髓嗜多染红细胞的微核率与生理盐水阴性组比较,差异无显著意义(P>0.05),而实验组与阳性组之间存在明显差异(P<0.05)。结论磷酸镁骨黏合剂不会引起人外周血淋巴细胞程序外DNA合成增加,也不会引起骨髓嗜多染红细胞微核率增加。提示此骨黏合剂不会引起DNA损伤,也不会引起骨髓细胞突变作用。展开更多
文摘In this paper our studies about the sequential testing program for predicting and identificating carcinogens, sequential discriminant method and cost- effectiveness analysis are summarized. The analysis of our database of carcinogeniclty and genotoxicity of chemicals demonstrates the uncertainty . of short- term tests ( STTs ) to predict carcinogens and the results of most routine STTs are statistically dependent. We recommend the sequential testing program combining STTs and carclnogenicity assay, the optimal STT batteries, the rules of the sequential discrimination and the preferal choices of STTs tor specific chemical class. For illustrative pmposes the carclnogenicity prediction of several sample chamicals is presented. The results of cost-effectiveness analysis suggest that this program has vast social-economic effectiveness.
文摘目的从遗传毒理学角度探讨磷酸镁骨黏合剂(magnesium phosphate cement,MPC)的遗传毒理学特性,为其在骨缺损修复领域的临床应用提供依据。方法将磷酸镁骨黏合剂制备浸提液,生理盐水作为阴性对照,采用程序外DNA合成(unscheduled DNA synthesis,UDS)检测法,硫酸镍为阳性对照,对渗入氚标记的胸腺嘧啶核苷(3H-TdR)的人外周血淋巴细胞液DNA做液体闪烁计数,测定3H-TdR掺入量的每分钟放射计数(radio counting per minute,CPM)值;采用小鼠骨髓嗜多染红细胞核试验,阳性对照组为环磷酰胺(CPA),测试其对小鼠股骨骨髓嗜多染红细胞的微核率。结果UDS试验结果显示:实验组(MPC浸提液)的CPM均值为35.98,而阴性对照组的CPM值仅为14.75,实验组不同浓度MPC浸出液的CPM值均略高于阴性对照组(生理盐水组),但差异无显著的统计学意义(P>0.05)。然而,考虑实验组MPC浸提液的CPM均值(35.98)远低于阳性对照组(不同浓度NiSO4)的CPM均值(415.38),且有显著的统计学差异(P<0.01)。因此,可以认为MPC浸提液不会引起DNA损伤。微核试验的结果显示:实验组引起股骨骨髓嗜多染红细胞的微核率与生理盐水阴性组比较,差异无显著意义(P>0.05),而实验组与阳性组之间存在明显差异(P<0.05)。结论磷酸镁骨黏合剂不会引起人外周血淋巴细胞程序外DNA合成增加,也不会引起骨髓嗜多染红细胞微核率增加。提示此骨黏合剂不会引起DNA损伤,也不会引起骨髓细胞突变作用。